Effects of mouse nerve growth factor, and monosialotetrahexosylganglioside on neurological symptoms after the operation of lumbar disc herniation

Fang YANG,Rong LIN
DOI: https://doi.org/10.3969/j.issn.2095-252X.2018.06.014
2018-01-01
Abstract:Objective To observe the therapeutic effects of mouse nerve growth factor, monosialotetrahe xosylganglioside on residual neurological symptoms after the operation of lumbar disc herniation. Methods From November 2014 to April 2017, 472 patients with residual neurological symptoms after the operation of lumbar disc herniation were collected. The total effective rate was obtained according to the improved symptoms after the treatment. All the patients were divided into 2 groups: Group A ( n = 240 ); Group B ( n = 232 ). Mouse nerve growth factor was used in Group A, while monosialotetrahexosylganglioside was used in Group B. The symptoms and signs in both groups were respectively recorded before and after the treatment. Visual analogue scale ( VAS ) and Oswestry disability index ( ODI ) were used in the evaluation. Results VAS, ODI were improved more significantly in Group A than that in the Group B ( P < 0.05 ). Incidence of cure and improvement in Group A ( 79.17% ) was significantly higher than that of the Group B ( 66.37% ) ( P < 0.05 ). Conclusions Mouse nerve growth factor performs better than monosialotetrahexosylganglioside to relieve the pain, which is more beneficial to the recovery of neural functions.
What problem does this paper attempt to address?